UNSPSC 51473603: 8-hydroxyquinoline

This classification denotes a topical anti-infective agent with the molecular formula C9H5Br2NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UK4C618C8T, chemically known as 5,7-dibromooxine but generally known as broxyquinoline, which bears US NIH Compound Identifier 2453. European Medicines Agency schedules Broxyquinoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05940MIG.

The term BROXYQUINOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules broxyquinoline in its Anatomical Therapeutic Chemical (ATC) Classification. BROXYQUINOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: BRC1C2C(NCCC2)C(O)C(BR)C1.

UNSPSC 51473603 8-hydroxyquinoline is a Commodity code with minimal relevant recent activity in state and local procurement. The recent opportunities tagged to this code do not align with its chemical product scope: a Hillsborough County Board of County Commissioners ITB for janitorial and operational supplies (response date July 24, 2026, estimated value $765,679.84) covers consumable cleaning and facility maintenance items for fire rescue operations, and a Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic pharmaceuticals and over-the-counter products (response date March 26, 2026) seeks manufacturers of FDA-compliant pharmaceutical goods. Neither solicitation reflects procurement of 8-hydroxyquinoline or related chemical intermediates.

The code shows no identifiable state or local solicitations targeting its nominal scope in the available recent-opportunities record. Jurisdiction-level chemical or industrial-materials procurement under this Commodity code does not appear in current public notices, and the two posted opportunities represent a mismatch between code assignment and actual work scope — one addressing facility consumables and the other pharmaceutical manufacturing. Business development professionals evaluating this code should treat current market activity as inactive unless the organization holds established relationships with state or local chemistry labs, water treatment systems, or industrial supply chains explicitly requesting this compound by specification.